Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
NCT02830724
Adenocarcinoma, Adnexal Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT Number: NCT06751498
The goal of this observational study is to develop a CNN-based machine module to predict postoperative fractional renal function in people who are proposed to undergo partial nephrectomy. The main question it aims to answer is:
• Does this machine learning model accurately predict renal function after partial nephrectomy?
Interested in participating?
Request Info18 year–80 year
All sexes
Observational
The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital), Nanjing, Jiangsu, China
This prospective study is conducted to predict postoperative fractional renal function using the perfusion deficit method from a preoperatively established renal arterial perfusion model for people who are proposed to undergo partial nephrectomy. In this study, this prediction method will be compared with the true missing values of renal units on nuclear renal function, eGFR, and CTA. This study aims to evaluate the feasibility of applying the CNN-based model in predicting postoperative renal function after partial nephrectomy and provide high-level clinical evidence for the preoperative integrated diagnostic and treatment process of renal tumors, especially in terms of the functional evaluation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months after surgery
Time frame: 3 months after surgery
Time frame: 24 hours, 1 month, 3 months, 6 months, 1 year after surgery
Contact information is provided by the study sponsor or research team.
Miao Haoqi, Postgraduate
CONTACT
Shao Pengfei, Professor
CONTACT
Shao Pengfei
Other
The Value of a Renal Artery Perfusion Model Based on Convolutional Neural Network in Predicting Renal Function After Partial Nephrectomy: A Prospective, Single-Center Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02830724
Adenocarcinoma, Adnexal Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06362369
ALK Genomic Tumor Aberrations, Adenocarcinoma
Aurora, Colorado, United States
View Trial DetailsNCT07294859
AKI - Acute Kidney Injury, Acute Kidney Injury
Nanjing, Jiangsu, China
View Trial DetailsNCT06676527
Adenocarcinoma, Antineoplastic Agents
Nanjing, Jiangsu, China
View Trial Details